Clinical trial
A Randomized, Double-Blind, Split-Face Controlled Study to Evaluate the Anti-Wrinkle Efficacy and Safety of a Syringic Acid-Containing Emulsion in Healthy Subjects
NCT07850817 is registered in ClinicalTrials.gov with BioSpectrum Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Split-Face Controlled Study to Evaluate the Anti-Wrinkle Efficacy and Safety of a Syringic Acid-Containing Emulsion in Healthy Subjects
- Lead sponsor
- BioSpectrum Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 12, 2015
- Completion date
- April 17, 2015
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
facial wrinkles, skin aging